Clover Health Investments Past Earnings Performance
Past criteria checks 0/6
Clover Health Investments has been growing earnings at an average annual rate of 11%, while the Healthcare industry saw earnings growing at 4.1% annually. Revenues have been growing at an average rate of 22.8% per year.
Key information
11.0%
Earnings growth rate
50.8%
EPS growth rate
Healthcare Industry Growth | 8.5% |
Revenue growth rate | 22.8% |
Return on equity | -13.6% |
Net Margin | -3.4% |
Last Earnings Update | 31 Dec 2024 |
Recent past performance updates
Recent updates
Clover Health: Expected Margin Contraction Is A Prelude To Exponential Growth
Mar 07We Think Clover Health Investments (NASDAQ:CLOV) Can Afford To Drive Business Growth
Feb 25Clover Health: Undervalued Turnaround Play With Promising SaaS Potential
Jan 16Recent Earnings Disappointment Could Be An Ideal Buying Opportunity For Clover Health
Dec 21Clover Health: Buy The Dip, Reap The Rewards
Nov 18Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
Nov 08Clover Health's Rally: The Payoff Of A Profitable Pivot
Nov 06There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump
Oct 03Clover Health: Changing Business Model, Seeking Profitability
Oct 03Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success
Aug 15Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement
Aug 14Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Aug 06Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jun 12Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues
Apr 20Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year
Mar 16Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?
Mar 06Clover Health: Its Luck May Have Ran Out
Feb 26Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Nov 21We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely
Jul 07Chamath Palihapitiya-linked Clover Health Investments trading near all-time low
Oct 14Revenue & Expenses Breakdown
How Clover Health Investments makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 24 | 1,371 | -46 | 409 | 0 |
30 Sep 24 | 2,115 | -96 | 406 | 0 |
30 Jun 24 | 2,090 | -121 | 418 | 0 |
31 Mar 24 | 2,059 | -157 | 422 | 0 |
31 Dec 23 | 1,263 | -210 | 440 | 0 |
30 Sep 23 | 1,864 | -226 | 457 | 0 |
30 Jun 23 | 2,441 | -268 | 473 | 0 |
31 Mar 23 | 2,989 | -344 | 486 | 0 |
31 Dec 22 | 1,199 | -255 | 482 | 0 |
30 Sep 22 | 3,041 | -443 | 476 | 0 |
30 Jun 22 | 2,564 | -402 | 478 | 0 |
31 Mar 22 | 2,075 | -615 | 468 | 0 |
31 Dec 21 | 1,361 | -588 | 446 | 0 |
30 Sep 21 | 1,158 | -527 | 387 | 0 |
30 Jun 21 | 922 | -487 | 314 | 0 |
31 Mar 21 | 721 | -160 | 247 | 0 |
31 Dec 20 | 690 | -136 | 192 | 0 |
30 Sep 20 | 624 | -89 | 186 | 0 |
30 Jun 20 | 572 | -145 | 177 | 0 |
31 Mar 20 | 507 | -272 | 185 | 0 |
31 Dec 19 | 455 | -364 | 187 | 0 |
31 Dec 18 | 281 | -202 | 187 | 0 |
Quality Earnings: CLOV is currently unprofitable.
Growing Profit Margin: CLOV is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CLOV is unprofitable, but has reduced losses over the past 5 years at a rate of 11% per year.
Accelerating Growth: Unable to compare CLOV's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CLOV is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (12.9%).
Return on Equity
High ROE: CLOV has a negative Return on Equity (-13.56%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/03/23 11:31 |
End of Day Share Price | 2025/03/21 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Clover Health Investments, Corp. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Kevin Fischbeck | BofA Global Research |
Richard Close | Canaccord Genuity |
Jason Cassorla | Citigroup Inc |